A high concentration of resiniferatoxin inhibits ion channel function in clonal neuroendocrine cells

Kenji Sugimoto1, Igor Kissin, Gary Strichartz

  • 1Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Abstract

Insights

Resiniferatoxin (RTX) acutely inhibits voltage-dependent calcium channels independently of TRPV1. Prolonged RTX exposure also affects sodium channels, with partial recovery observed.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Resiniferatoxin (RTX) is a potent TRPV1 agonist with potential pain control applications.
  • RTX's therapeutic effects may involve TRPV1-independent mechanisms.
  • This study investigates RTX's impact on ion channels independent of TRPV1.

Purpose of the Study:

  • To determine if RTX affects ion channels in a TRPV1-independent manner.
  • To evaluate the acute and prolonged effects of RTX on cellular excitability.

Main Methods:

  • GH(3) rat pituitary cells were loaded with fluo-4 dye.
  • Cells were stimulated with veratridine (VTD) or high K+ to assess ion channel activity.
  • RTX exposure effects on intracellular calcium ([Ca2+]) were measured via fluorescence.

Main Results:

  • Acute 10 microM RTX inhibited VTD and K+-stimulated [Ca2+] increases by 45-50%.
  • Prolonged (24h) RTX exposure significantly reduced VTD and K+-stimulated [Ca2+] responses (5.6-42% of control).
  • Responses to VTD showed partial recovery after 24h in RTX-free medium.

Conclusions:

  • RTX acutely inhibits voltage-dependent Ca2+ channels via a TRPV1-independent pathway.
  • Prolonged RTX exposure inhibits voltage-dependent Na+ channels in addition to Ca2+ channels.
  • These RTX-induced channel inhibitions are at least partially reversible.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...